本網站使用瀏覽器紀錄 (Cookies) 來提供您最好的使用體驗，我們使用的 Cookie 也包括了第三方 Cookie。相關資訊請訪問我們的隱私權與 Cookie 政策。如果您選擇繼續瀏覽或關閉這個提示，便表示您已接受我們的網站使用條款。 關閉
A star-studded weekend of events puts the Johnnie Walker Black Label 'Go Go Highball' center stage. KEY HIGHLIGHTS Johnnie Walker, the world's number one Scotch Whisky brand (IWSR 2024), celebrates in Los Angeles with activations inspired by partner Sabrina Carpenter across music's biggest weekend. Sabrina Carpenter's signature Johnnie Walker Black Label cocktail – The Go Go Highball – becomes the cocktail of the moment to toast to this year's achievements in music. Johnnie Walker serves as exclusive spirits partner at major weekend events, with surround-sound presence at the weekends' biggest parties. For a limited time, the Johnnie Walker Black Label Go Go Highball will be available at select Los Angeles bars including Melrose Umbrella, Roger Room and Hotel Figueroa LOS ANGELES, Jan. 31, 2026 /PRNewswire/ -- This weekend, Johnnie Walker, the world's number one Scotch Whisky brand (IWSR 2024), is celebrating music's biggest night in Los Angeles inspired by global partner, GRAMMY Award-winning artist and international superstar Sabrina Carpenter – with her signature serve – the Go Go Highball – set to become the drink of the moment. Johnnie Walker lights up the skyline of Los Angeles with large scale animations to celebrate music’s biggest weekend. As part of the next phase of this iconic partnership, originally announced in summer 2025, Johnnie Walker is celebrating with partner Sabrina Carpenter, who is nominated for 6 GRAMMY awards, with a weekend of high-impact moments across the city – from a striking cocktail projection to head-turning pre-and-post party experiences with Universal Music Group official weekend events and more. Landing squarely at the intersection of music, culture and celebration, Johnnie Walker is showing up at the biggest moment in the music calendar, continuing to partner with cultural trailblazers, and injecting new energy into the whisky category. The Go Go Highball – Sabrina Carpenter's signature Johnnie Walker Black Label serve inspired by a track on her latest album – was the centerpiece of Johnnie Walker celebrations during music's biggest weekend. Kicking off the awards' weekend in style, Johnnie Walker lit up the skyline of Los Angeles with large scale animations, and hosted a Sabrina Carpenter-inspired exclusive party at the legendary Max and Helen's on Larchmont Boulevard. The Los Angeles hotspot was transformed into a fantasyland with cherry-themed décor and floral accents blending pop romance, playful glamour and after-hours indulgence. Throughout the weekend, Johnnie Walker is taking center stage as the exclusive spirits partner at some of the city's biggest, most star-studded pre-and-post celebration events – making the Go Go Highball the must-have drink for the industry's leading music labels, nominees and winners. In a whimsical nod to Sabrina's sparkling style and the weekend's red carpet glamour, Johnnie Walker has also created a bespoke crystal embellished Highball clutch bag as a memento of the weekend for friends of the brand. For a limited time across Los Angeles, and to celebrate this big weekend, the Johnnie Walker Black Label Go Go Highball will also be available for consumers to try at select bars including Melrose Umbrella, Roger Room and Hotel Figueroa. Evolving the Johnnie Walker x Sabrina Carpenter Partnership "This moment is the perfect celebration of our partnership with Sabrina: raising a Go Go Highball to her progress and the incredible milestones she has achieved as an artist, against the backdrop of music's biggest weekend" said John Williams, Global Head of Whiskey at Diageo. "Working hand-in-hand with the newest voice in the Johnnie Walker story, we're excited to continue bringing a vibrant energy to the whisky experience." This weekend of collaborative celebration marks a significant and exciting evolution in the partnership between Johnnie Walker and Sabrina Carpenter, which originally launched ahead of the Short n' Sweet tour in August 2025. By partnering with voices like Sabrina, the brand continues to tell unique stories of progress and reshape the future of how and where people enjoy Johnnie Walker Black Label, from iconic stadiums and music venues to nightlife destinations across Los Angeles and beyond.
State-of-The-Art Heavy Modular Fabrication and Erection Manufacturing Facility to be Established in Andhra Pradesh with a Proposed Investment of USD 100 million GOA, India, Jan. 31, 2026 /PRNewswire/ -- India Energy Week : In a significant boost to India's industrial infrastructure, AG&P Industrial (Atlantic, Gulf and Pacific Company of Manila, Incorporated), a wholly owned subsidiary of AG&P International Holdings Pte. Ltd., Singapore, and a global pioneer in modular construction and Modstruction™ technology since seven decades, has entered into a Memorandum of Understanding (MoU) with Pragati Infra Solutions Pvt. Ltd. (PISL), a leading Indian EPC and infrastructure development company renowned for its strong execution capabilities, for setting up of country's first advanced modular EPC and fabrication manufacturing facility in Andhra Pradesh. (L-R) Mr. Shubhendra Mittal, Managing Director, PISL; Mr. Atul Gupta, Chairman and Managing Director-Designate, Engineers India Limited; and Ms. Anupam Ahuja, President, Corporate Strategy & Development, AG&P Group, at the MoU signing ceremony during India Energy Week 2026—India’s premier global energy platform—along with Promoter and other officials of PISL, and Engineers India Limited. This strategic partnership aims to create a long-term joint venture in India, focused on developing advanced fabrication yards, modular EPC (Engineering, Procurement, and Construction) infrastructure, and localized manufacturing for the oil & gas, LNG, and energy transition sectors. This partnership leverages AG&P Industrial's 70+ years of global leadership in modular construction, advanced fabrication, and full-asset lifecycle EPFCIC (Engineering, Procurement, Fabrication, Construction, Installation, and Commissioning) services, alongside Pragati Infra Solutions' deep expertise and execution capabilities in industrial infrastructure, renewable energy, and large-scale project development across India. The MoU was signed in the presence of Mr. Atul Gupta, Chairman and Managing Director-Designate, Engineers India Limited during India Energy Week 2026 – India's premier global energy platform. AG&P Industrial and PISL will each hold a 50 percent stake in the proposed joint venture, which involves an investment of USD 100 million. The facility is expected to be completed by 2027. Ms. Anupam Ahuja, President, Corporate Strategy & Development, AG&P Global, said, "We are excited to embark on a long-term partnership with PISL and proud to contribute to India's dynamic growth story. Our collaboration reflects India's transition from traditional, labor-intensive construction to productivity-driven, industrialized execution models. This shift is fueling demand for modular infrastructure and integrated delivery solutions that ensure faster, safer, and more predictable project outcomes. By combining AG&P Industrial's proprietary Modstruction™ methodology with PISL's large-scale project and infrastructure expertise, we will offer the speed, certainty, and scalability necessary to realize integrated, modular and future-ready infrastructure solutions for India's rapidly expanding energy, power, digital, industrial, and oil & gas sectors." Mr. Shubhendra Mittal, Managing Director, PISL, said, "Together, PISL and AG&P intend to develop a world-class fabrication and modularization yard in India, aligned with national priorities such as import substitution, energy security, and industrial self-reliance. Our platform is designed to closely support marquee EPC players across upstream, midstream, downstream, and gas infrastructure projects, while strengthening domestic manufacturing capabilities. In partnership with AG&P Industrial, we will expand in-country manufacturing capacity and jointly develop a state-of-the-art heavy modular fabrication and erection facility, with the core philosophy to maximizing production and bring globally benchmarked EPC and fabrication capabilities to India." The collaboration is poised to support the next phase of India's infrastructure, energy, and industrial development, and is aligned with the country's national productivity and digitization agenda, while delivering to the Government of India's vision of accelerating infrastructure and industrial growth, attracting foreign direct investment, and building a globally competitive manufacturing ecosystem under the 'Make in India, Make for the World' initiative. About AG&P Industrial A subsidiary of the AG&P Group, AG&P Industrial, Manila is a leading diversified provider of full-asset lifecycle EPFCIC (Engineering, Procurement, Fabrication, Construction, Installation, and Commissioning), infrastructure development, and O&M services. With a strong record of delivering award-winning projects worldwide—including LNG terminals, refineries, and complex process units—AG&P Industrial is known for its modular construction expertise and proprietary Modstruction™ methodology, enabling it to build large segments of projects and complex process modules in a controlled environment with the highest standards of safety and quality. For more information, visit www.agp-industrial.com About PISL Pragati Infra Solutions Private Limited (PISL), part of the Pragati Group, is a leading construction firm specializing in EPC services for both in-house projects and as a trusted contractor for multinational corporations and high-net-worth individuals. With over 16 years of industry experience and a strong ethical foundation, PISL has successfully delivered projects across millions of square meters in sectors such as copper smelting, food processing, radial wire manufacturing, automotive, heavy engineering, MSME, chemicals, logistics and warehousing and more. For more information, visit https://pislinfra.com/.
HONG KONG, Jan. 31, 2026 /PRNewswire/ -- The Compilation of Classics in the Flourishing Age: Exhibition of Achievements in Compiling A Comprehensive Collection of Ancient Chinese Paintings is on display at the City University of Hong Kong (CityUHK) from January 15 to February 6. The exhibition is presented through an institutional collaboration led by the Information Office of the Zhejiang Provincial People's Government, the Zhejiang Provincial Department of Culture, Radio, Television and Tourism, Zhejiang University, and CityUHK, and is supported by the CityUHK Cultural Exchange Oasis and Zhejiang University Press. As a focal moment of the exhibition program, Zhejiang University presented the first volume of the Collection of Pre-Qin to Tang Dynasties Paintings to CityUHK on January 30. The presentation took place in the context of an academic and cultural gathering bringing together over a hundred notable guests from academic, cultural, and government sectors. Attendees included Lin Zhan, Deputy Director-General of the Department of Publicity, Cultural and Sports Affairs of the Liaison Office of the Central People's Government in the HKSAR; Yu Hanyin, Deputy Director of the Publicity Department of the Zhejiang Provincial Committee and Director of the Information Office of the Zhejiang Provincial People's Government; Zhang Guangzhou, Member of the Party Leadership Group and Deputy Director of the Zhejiang Provincial Department of Culture, Radio, Television and Tourism; LAU Chun, Under Secretary for Culture, Sports and Tourism of the HKSAR; Zhou Jianghong, Vice President of Zhejiang University; Li Wenrong, Vice-President of CityUHK for Talent and International Strategy; and Lin Fen, Associate Vice-President of CityUHK for Global Strategy. The exhibition is divided into three sections: "Splendid Landscapes," "Flora in Full Bloom," and "Vibrant Society." The curatorial presentation is complemented by contextual displays of Zhejiang celadon, Song Dynasty floral arrangements, and artifacts related to The Knickknack Peddler. An accompanying public and academic program—including a "Chinese Artwork of the Day" feature, Song-style tea ceremonies, Zhejiang school guqin performances, and lacquer fan crafting workshops—offers visitors multiple points of engagement with the aesthetic principles and cultural life associated with the Song Dynasty.
SHANGHAI, Jan. 31, 2026 /PRNewswire/ -- Amid the surging wave of innovation in China's biopharmaceutical industry, a decade is long enough to witness the full evolution of a sector—from its initial emergence and growth to fundamental transformation. In 2015, as regulatory reform ignited local innovation, Lang Guojun, after earning his PhD from Zhejiang University and gaining several years of experience in pharmaceutical companies, foresightedly focused on the core upstream segment of the industry value chain and founded Sanyou Biopharmaceuticals (hereinafter referred to as "Sanyou Bio"). Standing at a new starting point ten years later, Lang Guojun reflects, "Time has passed incredibly fast—it feels like just the blink of an eye." Yet within this "blink of an eye," Sanyou Bio has achieved a leapfrog development, rapidly evolving from a startup with an initial antibody library at the 10^10 scale and a laboratory space of just 100 square meters into an industry front-runner. Today, Sanyou Bio has established an Intelligent Super-Trillion Antibody Library (STAL), the R&D platforms of super-trillion, intelligence and integration, as well as more than 20,000 square meters of operational and planned R&D and GMP-compliant facilities. Building on this foundation, in 2026, Sanyou Bio will officially launch its Innovation Hub for Original Drug Discovery (ClickLinks). At its core, the platform integrates global innovative drug R&D resources and leverages the Intelligent Super-Trillion Antibody Library to deliver a one-stop solution spanning drug discovery, preclinical development, and industrialization, while building an ecosystem network for original drug innovation. in collaboration with ecosystem partners, the platform will jointly fulfill the mission of "To provide solutions to accelerate biological drugs innovation globally." Lang Guojun admits that a decade ago, he never imagined Sanyou Bio would reach its current scale. His original intention was simply "to do whatever I can to contribute to new drug development." Perhaps this illustrates a simple truth: when one persists in doing the right thing, time often delivers rewards beyond expectation. 01 A Decade to Build a 10-Trillion–Scale Molecular Library Before founding Sanyou Bio, Lang Guojun had already spent many years in the pharmaceutical industry. He first worked at Henlius, a subsidiary of Fosun Pharma, holding positions across R&D and quality control. He later joined another company, focusing on product and marketing functions. This rare combination of experience across R&D, manufacturing, and commercialization endowed him with a multidimensional and holistic view of the industry. Thanks to this background, Lang Guojun keenly identified a critical "gap" in China's biopharmaceutical value chain around 2015. "At that time, commercialization, process development, and even clinical capabilities had already made solid progress," Lang Guojun recalls. "But at the very source—drug discovery and preclinical research—there was a severe shortage of platform-based companies." As China's pharmaceutical industry struggled to transition from generics to innovation, most players held a wait-and-see attitude. Lang Guojun, however, recognized both the core bottleneck and the greatest opportunity of the next decade: solving the fundamental challenges of drug discovery, which he believed represented the true value of platform companies. Looking back at the turbulent decade of innovative drug development, countless companies emerged and then faded away. Sanyou Bio, by contrast, advanced steadily and prudently. According to Lang Guojun, the company's ability to navigate industry cycles safely stems from its unwavering commitment to a dual-engine strategy of "R&D innovation" and "commercial operations," avoiding the fragility of a single-track model. "Many companies focus solely on R&D," he observes. "Once their funding dries up, even the best projects come to a halt." This dual-engine strategy has demonstrated remarkable resilience amid the recent capital crunch in the industry. "In 2024, we achieved break-even; in 2025, we built a solid profit base with sustained positive cash flow," Lang Guojun shares. "This not only ensures survival, but healthy survival." Survival is merely the prerequisite for the future. What truly anchors Sanyou Bio's position is its formidable technological moat. Over ten years, Sanyou Bio has built a 10-trillion–scale Intelligent Super-Trillion Antibody Library, which serves as the cornerstone of its competitiveness. Today, most domestic molecular libraries range from 10^10 to 10^11 in size. Sanyou Bio's library, at 10^13, is 100 to 1,000 times larger. "A 10^11-scale library may yield only dozens of candidate molecules," Lang Guojun explains. "A 10^13-scale library can theoretically generate thousands or even tens of thousands of lead candidates. This means that for any target, we can provide a rich pool of high-quality candidates, significantly increasing downstream R&D success rates from the very beginning." Yet even 10 trillion is not the endpoint. Sanyou Bio plans to continue expanding and upgrading its libraries. With the integration of AI technologies, next-generation libraries will move beyond randomness toward rational design, proactively selecting molecules and constructing optimal sequences to make libraries smarter and more efficient. In parallel, Sanyou Bio continues to expand molecular modalities—from full-length antibody libraries, to leading single-domain antibody libraries, and now trillion-scale peptide libraries—constantly pushing the boundaries of molecular forms. Looking ahead, the company also plans to explore the integration of peptides with nucleic acids to create the next generation of molecular libraries. 02 A Paradigm Shift in Innovation The confidence behind the Innovation Hub for Original Drug Discovery and its ambition to build an industry ecosystem extends far beyond Sanyou Bio's ultra-large molecular libraries. Over the past decade, Sanyou Bio has successfully delivered more than 2,000 projects for over 2,000 clients, building a deep and reliable customer network that underpins its strategic evolution. At the heart of this transition is a shift from traditional one-way CRO services to an open, efficient, and mutually beneficial ecosystem network. The Innovation Hub is designed as an open platform that integrates upstream and downstream resources to provide ecosystem-based comprehensive solutions. Its fundamental value lies in deeply engaging with and systematically empowering clients' innovation processes, thereby enhancing partners' long-term core competitiveness. This "deep empowerment" manifests across multiple layers of value creation, beginning with Sanyou Bio's role as a hub of resources and trust. Lang Guojun shares an example: a U.S.-based biotech company newly entering China urgently needed to connect with local CDMOs and safety evaluation institutions but faced delays due to unfamiliarity with the market. Leveraging its deep local insights and partnership network, Sanyou Bio not only precisely matched and introduced suitable partners, but also accompanied site visits and supported negotiations, ultimately ensuring successful project implementation. In this process, Sanyou Bio provided far more than technical services—it bridged information gaps and established trust. Moreover, through deep, mutually endorsed ecosystem relationships with strategic partners such as leading CDMOs, Sanyou Bio has embedded itself within a powerful industrial credit network. Strategic partners vouch for Sanyou Bio's technical expertise, while Sanyou Bio ensures the quality of recommended projects and clients, enabling more efficient access to premium resources and forming a virtuous cycle. On this foundation, the Innovation Hub assumes a dual empowerment role by systematically connecting critical breaks along the innovation chain. On one hand, it serves as a catalyst for translating scientific discoveries into development programs. Many academic laboratories hold promising early-stage targets but lack pathways for translation, while pharmaceutical companies often lack the bandwidth to evaluate and incubate such early projects individually. Sanyou Bio positions itself as a reliable bridge between upstream innovation and downstream development. "Sanyou Bio has built a dry–wet integrated intelligent platform, over 10,000 square meters of R&D facilities, and a comprehensive service chain spanning raw material preparation, antibody screening, antibody engineering, in vitro pharmacology, animal models, cell line development, purification process development, formulation development, and quality control," Lang Guojun notes. "While we do not engage in large-scale manufacturing, we have established a complete closed-loop capability from discovery through preclinical research." On the other hand, the Innovation Hub also functions as a matchmaker connecting capital and industry. Drawing on deep insights accumulated through extensive early-stage R&D involvement, Sanyou Bio can efficiently help investors screen and connect with high-quality projects, significantly reducing due diligence costs and information risks. After investment decisions are made, Sanyou Bio continues to provide professional R&D support, safeguarding projects from matchmaking through execution. In this sense, the Innovation Hub represents Sanyou Bio's strategic elevation of a decade of accumulated technology, experience, and networks into a dynamic ecosystem. Lang Guojun envisions Sanyou Bio evolving beyond a technical service provider into a central hub linking academia, industry, and capital—driving the new drug R&D ecosystem toward greater openness, efficiency, and shared success through resource connectivity, trust endorsement, and end-to-end technical support. 03 A First Look at the Innovation Hub: One-Click Access to R&D Resources In 2026, the Innovation Hub for Original Drug Discovery will officially go live. Presented as an integrated portal, the platform consolidates over 70 specialized service platforms or product pages into a unified interface, enabling clients to access required technical services or industrial resources through a single interface, dramatically reducing the complexity and cost of managing multiple vendors. At the same time, tools such as the OneClick+ Online Design Platform and the CRS marketplace, transform deep expert knowledge into standardized, user-friendly products and services, significantly shortening project initiation cycles. According to Lang Guojun, of the first 39 service modules launched, most are based on Sanyou Bio's proprietary end-to-end technology platforms. Moving forward, the Innovation Hub will selectively introduce and deeply integrate technology platforms from external strategic partners. Sanyou Bio will provide partners with free product definition, interface design, and content restructuring services, aiming to standardize technology modules from diverse sources and ensure a clear structure, seamless experience, and unified visual identity for users. As the central hub for all collaborations, the Innovation Hub will naturally accumulate interaction data from all projects, forming a globally scarce multimodal biopharmaceutical R&D data asset. This will lay a unique foundation for training proprietary AI-driven drug discovery algorithms and predictive models, establishing a long-term competitive moat. The platform's ecosystem value proposition operates on two levels. First, it serves as an open innovation platform that continuously aggregates and disseminates deep industry insights through its "Frontier Innovation" module, aiming to attract and retain high-value clients while building thought leadership. Building on this, the platform aims to unlock network value effects by systematically linking clients, suppliers, scientists, and innovators to promote efficient collaboration. Its long-term vision is that, through deep connectivity and trust-based mechanisms, the platform will ultimately enable direct partnership matchmaking, address long-standing trust and efficiency bottlenecks in the traditional value chain, and transform collaborative relationships into measurable "brand synergy" assets—culminating in a brand-new platform-based, network-collaborative business model. 04 "Don't Think About 20 Years Ahead—First Make 2026 the Best It Can Be" Standing at the threshold of the next decade, Lang Guojun describes his current mindset as a complex mix of "excitement" and "cautious vigilance." "Reaching where we are today has not been easy," he says. "We've grown from a team of three to more than 200 people. These ten years have laid a very solid foundation for the company." The caution stems from his clear understanding of business survival dynamics. "Ninety-five percent of companies don't survive beyond ten years, and even fewer last more than fifteen. Sustaining long-term success is extremely difficult." This acute sense of crisis keeps Lang Guojun grounded and pragmatic. "Rather than thinking about what things will look like in 15 or 20 years, our priority is to make 2026 the best version it can be." Going forward, Sanyou Bio will continue to uphold its dual-engine strategy of R&D innovation and commercial operations, striving to strike a balance between short-term growth imperatives and long-term sustainable development. In Lang Guojun's vision, Sanyou Bio will become one of China's key sources of innovative drug development—and the fundamental driving force behind it all remains the simple mission that inspired him at the very beginning: "To provide solutions to accelerate biological drugs innovation globally." About Sanyou Sanyou Biopharmaceuticals is a high-tech biopharmaceutical enterprise driven by its super-trillion molecule library and artificial intelligence technology, with the mission of "making innovative biologics R&D easy for clients worldwide". Sanyou Bio has been dedicated to developing a world-class innovative biological drug R&D hub. The company is centered on its AI-driven super-trillion antibody library (AI-STAL) and supported by its world-leading, integrated and intelligent R&D platform for innovative biologics development that seamlessly combines in silico and wet-lab capabilities. Sanyou drives the global development and industrialization of innovative new drugs through diversified business models. Headquartered in Shanghai, China, Sanyou has established global business centers across Asia, North America, and Europe, forming an international business network. The company currently operates and has planned over 20,000 square meters of R&D and GMP facilities. Sanyou has established strong collaborations with more than 2,000 pharmaceutical and biotech companies worldwide, empowering over 1,200 new drug discovery and development projects. It has completed more than 50 collaboration projects, over 10 of which have advanced to IND approval and clinical development stages. The company has filed over 130 invention patents, with more than 30 granted. It has also obtained over 10 national and international qualifications and system certifications, including National High-Tech Enterprise, Shanghai "Specialized and Innovative" Enterprise, ISO9001, and ISO27001.
Celebrating a new year filled with endless fun MACAO, Jan. 31, 2026 /PRNewswire/ -- As the Year of the Horse approaches, the city is alive with the vibrant energy of the season. To celebrate Chinese New Year, SJM Resorts, S.A. ("SJM") presents an exciting, and joy-filled festive journey across its hotels, resort, and food hall from 2 February to 8 March. Throughout the season, Grand Lisboa Palace Resort Macau ("Grand Lisboa Palace") will delight guests with an array of vibrant celebrations and exclusive privileges, including shopping rewards, lucky draws, and fun-filled family workshops. Guests can also gather with loved ones to savour exquisite reunion feasts at the MICHELIN-starred restaurants, or rejuvenate with revitalising treatments at the spa—embracing a prosperous and healthy start to the New Year. Restaurants at Grand Lisboa Palace and Grand Lisboa will present exclusive set menus and festive à la carte dishes. The festivities extend citywide, as Grand Lisboa Macau ("Grand Lisboa"), JAI ALAI Oceanus, L'Arc Macau, and Kam Pek Market are dressed in their holiday best. Adorned with dazzling décor, these destinations are ready to welcome guests from near and far, lighting up Macau with the year's brightest blessings and jubilant energy. Stop 1: Festive Photo Spots & Blessings from the God of Fortune Upon arriving at Grand Lisboa Palace, guests are instantly surrounded by a joyful and celebratory atmosphere, while the Jardim Secreto features six lively festive installations of SJM's mascot, Sam the Rooster—offering the perfect photo opportunity for families to capture cherished New Year memories. Meanwhile, the God of Fortune will make appearances at Grand Lisboa Palace, Grand Lisboa, JAI ALAI Oceanus, and L'Arc Macau, showering guests with auspicious goodies, dining, and shopping vouchers.[1] From 17 to 22 February, diners at Grand Lisboa Palace may have the chance to meet the God of Fortune and enter a lucky draw to win dining privileges. Guests at Grand Lisboa and JAI ALAI Oceanus can also redeem festive Fai Chun to bring the season's blessings home.[2] [1] The God of Fortune will appear and distribute red packets as follows:1st to 6th day of Chinese New Year (17–22 February) at Grand Lisboa Palace; 1st to 5th day (17–21 February) at Grand Lisboa and JAI ALAI Oceanus; 1st to 4th day (17–19 February) at L'Arc Macau. [2] With valid spending receipts, guests may redeem lucky Fai Chun as follows:27th day of the 12th lunar month to 1st day of Chinese New Year (14–17 February) at JAI ALAI Oceanus. 29th day of the 12th lunar month to 6th day of Chinese New Year (16–22 February) at Grand Lisboa. Stop 2: Spend & Win this Chinese New Year From 7 February to 8 March, guests who spend MOP100 or more at designated retail, dining, and spa outlets across Grand Lisboa Palace, Grand Lisboa, JAI ALAI Oceanus, or Kam Pek Market can enjoy access to Sam's Bouncy Castle and Sportopia. Those spending MOP300 or more can get on the Samtastic Express, symbolising a prosperous start to the New Year. Guests can also experience the Sam's Photo Booth, and take part in "the Year of the Horse Grand Lucky Draw" or "Grab & Win" Claw Machine with chances to win exclusive resort experiences, limited-edition souvenirs, and value of MOP16,888 Gold & Jewellery Voucher! Stop 3: Time-Honoured Traditions & Family Bonding The New Year roars to life with majestic lion dance performances, bringing good fortune to Grand Lisboa and Kam Pek Market on 21 February—as the troupe winds its way from Kam Pek Market to the Hong Kung Temple, spreading auspicious energy throughout the route. Performances continue with joyful flair on 22 February at Grand Lisboa Palace and on 23 February at JAI ALAI Oceanus and L'Arc Macau, welcoming the Year of the Horse with waves of prosperity and luck. The celebration extends citywide as the spectacular SJM Float joins the Macao Government Tourism Office's Chinese New Year Parade on the evenings of 19 and 28 February. Meanwhile, families can bond over creativity at the GLP Arte workshops on weekends from now to 28 February to craft personalised red packets, fuzzy wire potted plants, or lucky pinwheels. Stop 4: A Culinary Odyssey of Auspicious Flavours SJM's culinary masters will craft premium Chinese New Year delicacies starting from 1 February, featuring everything from opulent set menus and curated à la carte specialties to exquisite dim sum—an invitation to gather, feast, and savour the essence of the season. Palace Garden at Grand Lisboa Palace At Grand Lisboa Palace, the celebration is plated to perfection. Signature restaurants including Palace Garden, Chalou, and Hua Ting are launching limited-time set menus and auspicious à la carte dishes—ideal for sharing prosperity with family and friends. From 17 to 19 February, The Grand Buffet will host festive food stations and the traditional "Lo Hei" prosperity toss, symbolising rising fortunes and new beginnings. For a sweet interlude, La Scala del Palazzo, The Book Lounge, and Vivienne Westwood Café will serve elegant afternoon teas and festive pastries. Guests can also select from an array of rice pudding, Poon Choi, and premium hampers, to bring the flavour of happiness home. Hua Ting at Grand Lisboa Palace Robuchon au Dôme at Grand Lisboa will launch a special Chinese New Year set menu. On the evening of 19 February, guests can savour three-MICHELIN-starred French cuisine from one of the city's most spectacular vantage points, gazing upon the brilliant fireworks display during an unforgettable feast for both the eyes and the palate. The two-MICHELIN-starred The Eight will present its the Year of the Horse set menu, à la carte and dim sum selections. L'Arc Chinese Restaurant at L'Arc Macau will offer spring dinner menus for festive corporate or family gatherings, while JAI ALAI Oceanus joins the celebration with seasonal delicacies across Treasury Restaurant, Jai Alai Buffet Restaurant, CASA DE MASSA, and Treasure House. Chalou at Grand Lisboa Palace The Grand Buffet will host festive food stations and the traditional “Lo Hei” prosperity toss. Vivienne Westwood Café will serve elegant afternoon teas and festive pastries. Stop 5: Revitalise Your Glow for the New Year Greet the Year of the Horse with rejuvenated spirit and glowing vitality. From now until 31 March, SJM's world-class spas present exclusive treatments to reveal a radiant new you. The Spa at THE KARL LAGERFELD introduces the "Diamond Revival." Powered by the luxurious London skincare house 111SKIN, this treatment harnesses potent black diamond particles to firm and illuminate. Combining a lifting facial, body contouring, and restorative foot care, it ensures guests step into the Year of the Horse with glowing confidence. For a more holistic approach, The SPA at Palazzo Versace Macau presents the "Spring Rejuvenation with Traditional Chinese Therapy" from now until 28 February. Rooted in traditional wisdom, this therapy blends acupoint massage with warm moxibustion to dispel dampness and detoxify the body. Complemented by a complimentary back "Gua Sha" session, it melts away deep-seated stress and recharges the body with vital energy. The SPA at Palazzo Versace Macau presents the Spring Rejuvenation with Traditional Chinese Therapy throughout the Chinese New Year. Finally, The Spa at Grand Lisboa Palace offers the "Luminous New Year Indulgence". With qualifying retail purchases, guests can enjoy a complimentary 30-minute extension on their facial or body massage—an invitation to prioritise self-care and start the year with vitality. Unlock the complete journey of festive wonders, explore exclusive offers and surprises now at: https://www.sjmresorts.com/en/happenings/celebrate-the-year-of-the-horse-at-sjm - End -
SAN FRANCISCO, Jan. 31, 2026 /PRNewswire/ -- Dreame Robotic Vacuum hosted its launch event, The Age of Dreame Intelligence, in the heart of Silicon Valley's Stanford area, a premier global hub for technological innovation. Dreame Robotic Vacuum officially announced that it has secured the top market share in 30 countries and regions as of 2025. The event not only highlighted Dreame Robotic Vacuum's pioneering technological advancements in the global smart cleaning sector, but also underscored its visionary strategic direction and leadership within the industry. Dreame Robotic Vacuum Hosts The Age of Dreame Intelligence Launch Event in Silicon Valley As a core hub for global innovation, Silicon Valley's technological trends often reflect global market trends, with Stanford serving as a symbol of cutting-edge technological advancements. At this event, Dreame Robotic Vacuum showcased a range of high-end intelligent products, including the X60 Ultra robotic vacuum, CyberX stair-climbing robot, Cyber10 Ultra robotic arm, and Aqua10 Ultra Roller, marking a significant presence at the heart of global innovation. These innovations highlight Dreame Robotic Vacuum's leadership in the intelligent cleaning field and demonstrate its investment potential. Dreame Robotic Vacuum products showcased at the Silicon Valley launch event Just weeks before this launch event in Silicon Valley, Dreame Robotic Vacuum had made a major splash at CES 2026, where the X60 Ultra vacuum won 10 prestigious awards, once again becoming the focal point of the exhibition. The vacuum's ultra-slim 7.95cm profile offers unprecedented cleaning coverage, while its ultra-wide-angle binocular dynamic navigation and obstacle avoidance system accurately detects obstacles and quickly adapts to changes in its environment. Through these groundbreaking innovations, Dreame Robotic Vacuum has attracted substantial global investment, especially from Silicon Valley investors, accelerating the global rollout and expansion of its technology and products. Dreame Robotic Vacuum has achieved remarkable success in the global market. During the event, it was announced that Dreame Robotic Vacuum has secured the leading market share in 30 countries and regions, earning widespread recognition and demonstrating strong competitiveness. In key markets such as Poland, Germany, and Switzerland, its market share has consistently exceeded 40%. Meanwhile, its expansion across North America, Asia-Pacific, the Middle East, and South America is accelerating. As of now, Dreame operates in over 120 countries and regions, with more than 6,500 retail outlets worldwide. The Silicon Valley launch event not only reinforced Dreame Robotic Vacuum's position as a trailblazer in global innovation but also highlighted its continued deepening of strategic market and capital initiatives. Looking ahead, Dreame Robotic Vacuum is poised to continue spearheading high-end, forward-thinking innovations, offering sustained value and confidence to both consumers and investors. CONTACT: Angie Zhang, zhanganji@dreame.tech
A12 藝術空間
請先登入後才能發佈新聞。
還不是會員嗎？立即 加入台灣產經新聞網會員 ，使用免費新聞發佈服務。 （服務項目） （投稿規範）
